The NG2 proteoglycan is of general interest after spinal cord injury because it is expressed by oligodendrocyte progenitors (OPCs), which contribute to central nervous system remyelination; however, NG2 may inhibit axon regeneration. We and others have examined the spatiotemporal expression of NG2 after spinal cord injury (SCI). Here, we extend those observations and provide a comprehensive analysis of the distribution, phenotype, and colocalization of NG2 cells with axons in a clinically relevant model of spinal contusion. Because contusion models mimic the majority of human SCI, this information is important for understanding endogenous processes that promote and/or prevent repair. The data demonstrate that NG2 levels rise significantly between 3 and 7 days postinjury (dpi) and remain elevated chronically throughout the lesions. NG2 within the lesions could be derived from an array of infiltrating cells; thus, a panel of antibodies was used to investigate NG2 cell phenotypes. First, platelet-derived growth factor-> receptor (PDGF>R) colocalization was examined because OPCs normally express both markers. PDGF>R cells were present in lesions at all times examined. However, only 37% of NG2 cells coexpressed PDGF>R at 14 dpi, which dropped to G1% by 70 dpi. This contrasts with the nearly complete overlap in spared tissue surrounding the lesion. In contrast, 40% to 60% of NG2 cells expressed p75 and approximately 84% expressed Sox10, suggesting that many NG2 cells were nonmyelinating Schwann cells. Despite rising levels of NG2, we noted robust and sustained axon growth into the lesions, many of which were located along NG2 profiles. Thus, spinal contusion produces an NG2-rich environment into which axons grow and in which the source of NG2 appears considerably different from that in surrounding spared tissue.
INTRODUCTION
During central nervous system (CNS) development, oligodendrocytes arise from cells called oligodendrocyte progenitors (OPCs), which express NG2 and platelet-derived growth factor-> receptor (PDGF>R) (1, 2) . Interestingly, a subset of these cells persists into adulthood, which retains the ability to differentiate into oligodendrocytes (3) . Indeed, several studies suggest that adult OPCs participate in CNS repair by entering demyelinated lesions and then differentiating into remyelinating oligodendrocytes (4Y7). Collectively, these studies reveal that adult NG2 cells play an important reparative role after oligodendrocyte loss and demyelination. NG2 cells also respond to other CNS pathologies, including stab wounds (8Y10), viral infections (11) , and spinal cord injury (SCI) (12Y14). The function of reactive NG2 cells in these models is currently unknown.
In a previous study, we characterized the proliferative response of OPCs to spinal contusion lesions, which are the most common SCI sustained by humans (15) . In that study, we observed NG2 cell proliferation for at least 28 days postinjury (dpi) (12) . It was noted, however, that some NG2 cells in the lesions displayed macrophage morphology, suggesting that NG2 in the lesions did not originate from OPCs alone. Recent studies have also demonstrated expression of NG2 by other cell types, including macrophages, fibroblasts, Schwann cells, and pericytes (12, 14, 16Y21) . Thus, although NG2 is normally restricted to OPCs, NG2 cells in spinal lesions may be comprised of a mixed population of cells.
In the present study, we used a rat contusion model to characterize the distribution and cellular sources of NG2 immunoreactivity throughout the lesions. NG2 expression in the lesions was compared with markers typically associated with OPCs (e.g. PDGF>R), Schwann cells (e.g. p75, P0), fibroblasts/meningeal cells (fibronectin), and macrophages (ED-1). We also examined expression by NG2 cells of Sox10, a transcription factor in cells of oligodendrocyte and Schwann cell lineages (22, 23) . In addition, global changes in NG2 immunoreactivity over time were measured throughout the pathologic tissue. Lastly, because the function of NG2 cells in the lesions may include axon myelination and/or directing axon growth, we compared the distribution of NG2 and axons within the lesions.
Collectively, the results reveal that in contrast to knifecut injuries, elevated NG2 was sustained for at least 4 months at the impact site. Surprisingly, only one third of NG2 cells in the lesions expressed PDGF>R early after injury, which declined to G1% by 70 dpi. Therefore, putative OPCs contributed only minimal NG2. However, a large percentage of NG2 cells double -labeled with p75 or laminin, suggesting a nonmyelinating Schwann cell phenotype. This was further supported by the high percentage of NG2 and p75 cells expressing Sox10. As expected, NG2-positive macrophages and vascular profiles also were present, which contributed to the chronically high NG2 levels. However, few NG2 cells coexpressed fibronectin, indicating that infiltrating fibroblasts contributed little NG2. Lastly, many axons in the lesions were located on or completely surrounded by NG2 processes. Some of these axons expressed GAP-43, suggesting they were in a growth state, which is supported by the observation of a quantifiable increase in axon profiles over time in the lesions. A subset of axons associated with NG2 expressed serotonin or tyrosine hydroxylase, indicating a brainstem origin. Therefore, the presence of the NG2-rich environment did not prevent endogenous axon growth into the lesioned tissue and many axons therein were in direct contact with NG2 cells.
MATERIALS AND METHODS

Spinal Cord Injury
Adult female Fischer 344 rats (180Y190 g) received a moderate contusion injury using the OSU electromagnetic spinal cord injury device as previously described (12) . Briefly, rats were anesthetized with 80 mg/kg ketamine and 10 mg/kg xylazine and a partial laminectomy was performed at vertebral level T 8 . A computer-controlled impact probe was slowly lowered until it reached the dural surface. Next, the probe was rapidly driven 1.1 mm into the spinal cord over 23 msec, producing a closed dural injury. The injury site was surgically closed and the animal was hydrated and placed in a warmed recovery cage. Animals received daily antibiotics and manual bladder expression until return of automatic voiding, typically 10 to 14 days postinjury. This injury level produces a moderate SCI in which animals recover the ability to step in a noncoordinated manner (score of 11 on the Basso, Beattie, Bresnahan [BBB] scale [24] ).
Tissue Processing and Immunohistochemistry
Rats were randomly placed in groups that survived for 3, 7, 14, 28, 70, or 112 dpi (n = 4Y6/group). An additional 4 uninjured rats were included as noninjury controls. At the designated time, rats were deeply anesthetized and perfused intracardially with phosphate-buffered saline (PBS) followed by 4% paraformaldehyde. Spinal cords were removed, postfixed for 2 hours, and transferred to 0.2 M phosphate buffer overnight. Cords were then transferred to a 30% sucrose solution until they sunk, typically at 24 to 48 hours. Spinal cords were blocked into five 2-mm segments, one centered on the injury site, the rest at 2 mm and 4 mm rostral/ caudal to epicenter; blocks from each animal were sequentially placed into a cryomold, frozen in OCT (VWR International, Bridgeport, NJ) on dry ice, cut as cross-sections on a cryostat at 10 Km, and placed onto Superfrost slides (Fisher Scientific, Pittsburgh, PA). In this way, all analyzed sections from each animal were immunolabeled simultaneously.
Spinal cord sections were labeled immunohistochemically with a variety of antibodies, including rabbit anti-NG2 (Chemicon, Temecula, CA), mouse anti-NG2 and mouse anti-PDGF> receptor (gifts of William Stallcup), mouse antineurofilament (heavy chain-RT97; Boehringer Mannheim, Germany), rabbit antiserotonin (Eugene Tech International, Ridgeford Park, NJ), mouse antityrosine hydroxylase (Chemicon), rabbit antilaminin (Sigma, St. Louis, MO), rabbit antifibronectin (Sigma), rabbit anti-p75 (Promega, Madison, WI), rabbit anti-Sox10 (Chemicon), and mouse anti-P0 (Dr. Juan Archelos, Society to Support Research, Diagnosis and Treatment of Neurological Disorders, Austria). Briefly, for immunoperoxidase labeling, nonspecific binding was blocked in a solution of 10% serum plus 0.1% Triton-X-100 in PBS. After rinsing, primary antibody was applied overnight at 4-C. The next day, secondary antibody was applied for 1 hour at room temperature; sections were rinsed and treated with DAB or SG substrate (Vector Laboratories, Burlingame, CA). Sections were dehydrated and coverslipped.
For fluorescent double labeling, sections were incubated in 4% BSA with 0.1% Triton-X in PBS for 60 minutes. Next, monoclonal and polyclonal primary antibodies were mixed and applied to sections overnight at 4-C. Sections were rinsed and secondary antibodies applied for 30 minutes (Alexa-Fluor 488 goat antimouse, Alexa-Fluor 546 goat antirabbit; Molecular Probes, Eugene, OR). Sections were rinsed with PBS; DAPI or DRAQ5 (Biostatus, Leicestershire, U.K.) was added to the final rinse to label nuclei. Slides were coverslipped with Immu-mount (Shandon, Pittsburgh, PA). Controls for each staining combination included omitting primary or secondary antibodies, which resulted in an absence of labeling (Fig. 1) . In addition, all antibodies were tested alone to verify the pattern observed replicated that seen using in double-labeling procedures. Single optical sections (G2 Km) were captured using a Zeiss 510 META Laser Scanning Confocal microscope and saved as red, green, blue, and merged images. Images were imported into Photoshop 7.0.1, in which background was subtracted and contrast enhanced when necessary.
Quantitation of NG2 and Neurofilament Immunohistochemistry
Sections labeled for NG2 spanning 8 mm of spinal cord centered on the epicenter (1Y2 sections/region/rat; n = 4Y5/group) were digitized using the MCID Elite image analysis system (Imaging Research, Inc., St. Catharines, Canada). Digitized images were manually outlined, taking care to exclude NG2 + meninges on section edges (13, 25) , which avoided artificial inflation of NG2 levels. Cavities within the sections were excluded from analysis, because the goal was to determine the proportion of tissue expressing NG2. Next, the segmentation range was set such that only positively labeled NG2 was selected. The cross-section area was determined and the amount of NG2 within that area was quantified as Btarget area,[ which was divided by crosssection area to determine Bproportional area,[ or the percent of tissue containing NG2. Data obtained at each time point were averaged and expressed as mean T standard error of mean. Results were compared with data collected from naive noninjured spinal cords using 2-way analysis of variance followed by Bonferroni multiple comparisons test.
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Two epicenter cross-sections per animal immunolabeled for neurofilament were digitized as previously mentioned (n = 4Y5/group) and the segmentation range set so that positively labeled axon profiles were selected. Depending on lesion size, 3 to 5 nonoverlapping 0.048 mm 2 sample boxes were positioned in the lesions and the amount of positive label quantified in each box as target area. Sample boxes were arranged to include the maximum lesion area possible. Values for each animal were averaged and group means for each time postinjury were compared using oneway analysis of variance following by Tukey's multiple comparison test.
Quantification of Cell Populations Within Epicenter Lesions
To examine changes in cell populations in lesions over time, optical sections (G2.0 Km) were captured using a Zeiss 510 META Laser Scanning Confocal microscope (n = 4Y5/ group). Three to 5 nonoverlapping sample fields (0.048 mm 2 ) were captured in each lesion; this strategy allowed evaluation of the majority of the lesion area. Captured singlechannel and merged images were viewed using the LSM 5 Image Browser software (Zeiss, Germany). All single-labeled and double-labeled cells were counted in each box and the number of cells/mm 2 determined. Comparable measurements were also made in midthoracic cross-sections of naive spinal cords (n = 4; 2 sections/rat). In each section, samples (0.048 mm 2 ) were collected in the dorsal funiculus, dorsolateral funiculi, lateral funiculi, and ventral funiculi (7 boxes total); all single-and double-labeled cells were counted and the number of cells/mm 2 determined. Data for each rat was averaged and group means determined.
RESULTS
NG2 Increased by 7 Days Postinjury and Remained Elevated Chronically Throughout the Lesion
At 3 dpi, tissue pathology was evident in sections 4 mm distal to the epicenter ( Fig. 2A) . Over time, NG2 levels rose within lesions and at the lesion-spared tissue border (Fig. 2B, C) . Elevated NG2 was especially prevalent on tissue bridges throughout the cavities (Fig. 2BYF ). As shown in Figure 2 , the total amount of tissue present decreases over time as ongoing cavitation replaces tissue damaged by the initial trauma. Consequently, NG2-expressing cells occupy a larger proportion of the remaining tissue over time.
NG2 immunoreactivity was quantified in the epicenter and sections 2 to 4 mm rostral/caudal (Fig. 2G ). Data are expressed as the proportion of tissue displaying NG2 immunoreactivity and are compared with uninjured thoracic spinal cords, in which NG2 immunoreactivity comprised 6% to 7% of the cross-sectional area. In sections 2 to 4 mm rostral to epicenter, NG2 increased more than 2-fold by 7 dpi, rose again at 28 dpi, and persisted through at least 70 dpi. In the epicenter region, NG2 levels rose significantly between 3 and 7 dpi and continued to rise through 70 dpi, at which time >50% of tissue was positive for NG2. This level was maintained for at least 112 dpi. Caudally, NG2 expression was similar to that seen rostrally, i.e. NG2 continually increased so that by 70 dpi, levels were 4-to 5-fold greater than controls. Thus, at least 8 mm of spinal cord tissue displayed chronically elevated NG2 levels. Overall, the continual rise in NG2 proportional area was the result of increasing NG2 cell numbers inside the lesions (see subsequently) and decreasing total cross-sectional area as cavitation and tissue loss proceed throughout the lesions. This is in line with our previous data demonstrating significant NG2 cell proliferation for at least 28 days after contusion injury (12) .
Comparison of NG2 and PDGF>R Expression
In the current study, 99% of NG2 cells (approximately 85 cells/mm 2 ) sampled in white matter of normal spinal cords were double-labeled with PDGF>R, which was compared with cells in the SCI lesions. At 7 dpi, cells expressing NG2 or PDGF>R were scattered throughout the lesions (200Y279 cells/mm 2 ; Figs. 3 and 4A, B). These cells were located in close vicinity, yet only 15% of NG2 cells were double-labeled for PDGF>R (Fig. 3) . The overall number of NG2 and PDGF>R cells in the lesions increased by 14 dpi, at which time 37% of NG2 cells coexpressed PDGF>R (Fig. 3) . By 28 dpi, NG2 cell numbers had doubled, whereas PDGF>R cell numbers had remained constant, and only occasional double-labeled cells were observed (Fig. 4C) . By 70 dpi, PDGF>R cell numbers had slightly increased, whereas NG2 cells had increased by >50% (Fig. 3) . Although the cell populations remained closely intermingled, the percentage of double-labeled cells decreased to G1% at 70 dpi ( Figs. 3 and 4D ; Table 1 ). At this time, closely packed PDGF>R cells often appeared as sheets of contiguous cells (Fig. 4E) . The dissociation between PDGF>R and NG2 after SCI was restricted to the lesions. That is, PDGF>R cells in spared tissue around the lesions were double-labeled for NG2, as expected (Fig. 4F) .
Comparison of NG2 and p75 or P0, Markers Found in Unmyelinating and Myelinating Schwann Cells, Respectively
These data suggest that the majority of NG2 cells in the lesions were not OPCs. As stated previously, nonmyelinating Schwann cells express NG2 in some instances and are known to migrate into contusion sites (19, 20, 26Y30) . Thus, we examined the number of cells expressing NG2 and p75, a surface receptor on nonmyelinating Schwann cells.
In normal spinal cords, p75 is restricted to small axons in the dorsal horns and select axons in the dorsal columns. After SCI, p75 increased within the lesions in a pattern that closely mirrored that of NG2. By 7 dpi, a comparable number of p75 and NG2 cells were present in the lesions (173Y178 cells/mm 2 ), half of which were double-labeled (Figs. 5AYD and 6 ). By 14 dpi, p75 cells had doubled and NG2 cells had increased by 50%; 40% of the NG2 cells expressed p75 at this time (Fig. 5E) . By 28 dpi, NG2 and p75 cell numbers had again risen, and 59% of NG2 cells expressed p75 (Figs. 5F and 6). NG2 and p75 cell numbers continued to rise, such that by 70 dpi, the average numbers were 704 and 629 cells/mm 2 , respectively. At this time, 41% to 45% of the cells were double-labeled (Figs. 5GYI and 6; Table 1 ). Collectively, these data reveal that NG2 cell number in the lesions rises over time and that at least 2 pools of NG2 cells are present, one of which expresses p75. Reactive NG2 cells bordering the lesions were negative for p75.
Meningeal fibroblasts, which infiltrate contusion lesion, have been reported to express PDGF>R and p75 (25, 31 ). Thus, it was possible that NG2-negative p75 + cells belonged to the PDGF>R cell population, of which G1% expressed NG2 chronically. In sections double-labeled for these 2 receptors, single-labeled cells were closely intermingled throughout the lesions. However, cells coexpressing both markers were not observed (Fig. 5JYL) . Therefore, p75 cells and PDGF>R cells are distinct populations.
To further investigate NG2 expression by Schwann cells, sections were double-labeled for NG2 and laminin, which is expressed by myelinating and nonmyelinating Schwann cells (32) . Laminin expression by OPCs has not been reported, and, accordingly, double-labeled cells were not present in spared tissue, with the exception of select vascular profiles (data not shown). Within the lesions, double-labeled cells were observed in the first 2 weeks after injury near the dorsal edge and lesion borders. At more chronic times, double-labeled profiles were prevalent throughout the lesions in a pattern similar to the p75/NG2 cells (Fig. 7AYD) . In addition, NG2/laminin + vessels also were observed in the lesions. However, these did not comprise the entire NG2/laminin cell population, because they had markedly different profiles and were easily distinguished.
Subsets of Schwann cells that enter the lesions or spared tissue differentiate into myelinating cells. Thus, sections were double-labeled with NG2 and P0, a protein found in peripheral but not central myelin. Schwann cell myelin was consistently found in the dorsal funiculus, throughout the lesions, and in varying regions of spared tissue (Fig. 8AYD) . At no time or location were doublelabeled P0 and NG2 profiles observed, indicating that myelinating Schwann cells do not express NG2. This was corroborated by the absence of NG2 on laminin + rings in the spared white matter, which correspond to regions of Schwann cell myelin (Fig. 8E, F) . (18, 21, 25, 31, 34) . Thus, a portion of NG2 in the lesions may be derived from these cells. To examine this, epicenter sections were labeled for NG2 and fibronectin. Although fibronectin immunoreactivity increased inside the lesions over time, NG2 and fibronectin double-labeled cells were rare (Fig. 9A) , with the exception of vascular profiles.
Comparison of NG2 Expression
Several studies have shown that macrophages present after spinal trauma or other injuries can upregulate NG2 (12, 14, 16) . Because high numbers of macrophages are present in contusion lesions as early as 7 dpi (35), sections were labeled for NG2 and ED-1 to label phagocytic macrophages. Indeed, as early as 7 dpi, a subset of ED-1 + macrophages was double-labeled with NG2 (Fig. 9B) . Therefore, activated macrophages contribute a portion of the elevated NG2 measured in the lesions (Fig. 1) . Because these cells can be clearly distinguished morphologically, they were not included in the NG2 cell counts described here.
Sox10 Expression by NG2 and p75 Cells in the Lesion
Because fibroblasts were excluded as a major source of NG2, we investigated further if NG2 and p75 cells were of a glial origin by labeling sections for p75 or NG2 and Sox10, a transcription factor expressed by oligodendrocyte and Schwann cell lineage cells (22, 23) . Expression by other cell types has not been reported. At all times examined (i.e. 7Y70 dpi), an average of 84% of NG2 or p75 cells in the lesions contained Sox10 + nuclei, suggesting they were of a glial origin (Fig. 10A, B ; Table 1 ).
Axons Grow Into the Lesions Over Time and Become Colocalized with NG2 and p75
It has been reported that spontaneous axon growth occurs into SCI lesions over time (36Y41). This phenomenon was also observed in the present study. That is, by 3 dpi, intact axons were rare inside the lesions; over time, however, the number of neurofilament-positive profiles in the lesions increased significantly, especially between 3 and 28 dpi (Fig. 11AYC) . Many of these axons had tortuous orientations and were located within tissue bridges shown here to be NG2-immunoreactive (Fig. 2) . Of the few axons inside 7 dpi lesions, many were in close contact with NG2 processes (Fig. 12A, B) . The axons were adjacent to and in places completely enwrapped by NG2 (Fig. 12B) . Over time, the number of axons contacted and enwrapped by NG2 increased (Fig. 10C, D) . By 70 dpi, axons were prevalent within NG2-rich tissue bridges and were often surrounded by NG2 processes (Fig. 12E, F) . A subset of axons expressed GAP-43, suggesting that axons in an active growth state at 70 dpi were in contact with NG2 (Fig. 12G) . Sections double-labeled for p75 and axons revealed a similar wrapping of axons by p75 + processes (data not shown). A portion of axons in contact with NG2 was of supraspinal origin, as determined by labeling with tyrosine hydroxylase or serotonin antibodies (Fig. 12H, I ). Thus, despite the ongoing rise in NG2 in the lesions, axon growth was not prevented. In contrast, axons were located throughout regions rich in NG2 immunoreactivity, in which they often closely apposed NG2 processes, as confirmed by 3-dimensional reconstruction of z-stack images (Fig. 13) . Spared axons in surrounding white matter were not enwrapped by NG2, indicating that this relationship was restricted to axons growing into the injury site.
DISCUSSION
NG2 expression has often been used to identify oligodendrocyte progenitor cells (1) , which react to CNS injuries with proliferation and increased NG2 expression. In the current study, the data collectively reveal that NG2 is upregulated by 7 dpi and maintained chronically within and around lesion cavities. Compared with PDGF>R + OPCs in spared tissue, NG2 cells inside lesions expressed a different complement of markers, and many of these cells were closely associated with growing axons.
Chronic Elevation of NG2 Throughout Contused Spinal Tissue
In the present study, NG2 immunoreactivity rose between 3 and 7 dpi, resulting in a >2-fold increase compared with naive spinal cords. This is in line with previous work showing maximal NG2 cell proliferation occurs during the first week postinjury (12, 42) . Interestingly, NG2 continued to rise throughout the lesions over time, resulting in a significant elevation as late as 112 dpi, which correlates with the continual rise in NG2 cells counted in the lesions. Spinal parenchyma at the lesion/border interface also contained reactive cells displaying high levels of NG2. Thus, throughout the entire rostrocaudal extent of tissue pathology (>8 mm), NG2 proteoglycan was elevated within and around the lesions.
The present results contrast somewhat with data by others using dorsal spinal knife cuts in which NG2 rose within 1 mm of the lesion and peaked 1 to 2 weeks postinjury (13, 14) . The protracted rise in NG2 in our model likely is the result of the greater pathology caused by contusion injury and the accompanying progressive cavitation. This model may induce a larger number of NG2 cells to proliferate, which would contribute to higher and prolonged NG2 levels. Indeed, our current data reveal that NG2 cell numbers continually rise over time inside the lesions, which may be the result of chronic proliferation and infiltration from the surrounding tissue. At first glance, this may seem to contrast with our previous work showing a decrease in NG2 cell proliferation between 4 and 10 weeks postinjury (12) . However, the percentage of NG2 cells dividing at 10 weeks postinjury remained 2 to 3 times higher near the epicenter compared to uninjured controls (12) . It is also possible that the absolute number of NG2 cells in the lesions did not change over time, but that the area available for them to occupy was continually reduced by ongoing cavitation. Assuming these cells survived the tissue loss, they would be forced to coalesce into the remaining tissue. However, the same trend was not noted for the PDGF>R cell population, whose numbers were fairly constant between 28 dpi and 70 dpi.
Colocalization of NG2 and Axons
It is generally believed that the CSPG-rich glial scar formed after CNS trauma inhibits axon regeneration (43, 44) . In vitro studies have shown that NG2 in particular causes growth cone collapse and inhibits neurite growth (34, 45Y48). Therefore, the high level of NG2 expressed within and around SCI lesions could provide a significant impediment to axon regeneration. In the present study, however, we found that axon profiles in the lesions continually increased over time despite the upregulated NG2. Furthermore, many of these axons were contacted or completely surrounded by NG2 processes. Axon growth into the lesions occurred over the same time course as NG2 infiltration. That is, few to no axons were present in 3 dpi lesions, after which the numbers rose over time, which has been noted in other studies as well (36Y41). In fact, the presence of GAP-43 + axons in lesions at 70 dpi suggests that some axons were still in a growth state chronically. Therefore, it cannot be determined in the current study which came firstVaxons growing on NG2 profiles or NG2 cells approaching axons. Many axons were completely encircled with NG2, which may indicate that the axon was present first. If NG2 cells are comprised at least partially of premyelinating cells, as our data suggest, then they may be drawn to axons as a prelude to myelination. Several examples of axons situated along and within NG2-rich areas also were observed, raising the possibility that axons grew on NG2 profiles. Given the prevalence of NG2-laminin double-labeling inside the lesions, it is possible that the balance of growth-inhibiting and growth-supporting characteristics were such that axon growth was not prevented, as has been suggested previously to occur in fibroblasts transplanted into a spinal hemisection injury (49) .
Although most humans sustain spinal contusion injuries, the relationship between NG2 and axons in a contusion model has not been examined previously. Because the pathology after closed dural contusion is different from that following spinal transection or hemisection, it is important to understand the lesion environment that regenerating axons will encounter in a model that closely mimics a large proportion of human injuries. As shown here, there is extensive upregulation of NG2 for several millimeters inside and around the injury. Despite this fact, axon growth seems to preferentially occur within the lesions. Data from other studies also suggest that inhibition of neurite growth by NG2 is not always absolute in vivo. For instance, growing axons were associated with NG2 in regenerating peripheral nerves and in ascending sensory axons growing along NG2 + vessels after spinal compression injury (19) . Furthermore, a recent report by de Castro et al suggests that NG2 may actually promote serotonergic axon growth after spinal transection (25) . Our current data are in accordance with that finding, as we observed serotonergic and tyrosine hydroxylase axons in contact with NG2, revealing that descending axons interact with NG2 after spinal contusion. A better understanding of NG2Yaxon interactions will facilitate the targeting of potential regenerative therapies for humans.
Oligodendrocyte Progenitor Cells as a Source of NG2 Within the Lesion
In the normal adult CNS, NG2 and PDGF>R are coexpressed by a population of glial cells called oligodendrocyte progenitors or polydendrocytes (3, 50) . OPCs respond to CNS insults with rapid upregulation of NG2, proliferation, and migration into lesions. Division of NG2 cells is likely a reparative attempt by CNS tissue, because OPC proliferation occurs before differentiation into oligodendrocytes (51) . This would suggest that much of the upregulated NG2 measured throughout lesions was derived from reactive OPCs, especially given that most NG2 cells expressed Sox10 (22, 23) . However, relatively few cells were double-labeled for NG2 and PDGF>R acutely and essentially no overlap occurred chronically. This contrasts with nearby spared white matter, where PDGF>R cells coexpressed NG2, indicating that they were typical OPCs. Within the lesions, the small percentage of cells coexpressing NG2 and PDGF>R may indeed be reactive OPCs, but the identity of the numerous single-labeled PDGF>R and NG2 cells is less clear. The PDGF>R cells could conceivably be nonmyelinating Schwann cells (52) ; however, no overlap between PDGF>R and p75 was observed, making it unlikely that they were Schwann cells (53, 54) . It is possible that the NG2-negative PDGF>R cells were fibroblasts. Unfortunately, antibody incompatibilities prevented a direct comparison of PDGF>R and fibronectin. PDGF>R cells, which appeared morphologically as macrophages or blood vessel constituents, also were noted but were not included in the cell counts.
Over time, approximately half the NG2 cells expressed p75, which suggests a Schwann cell phenotype (see subsequently). The identity of remaining p75-and /PDGF>R-negative NG2 cells inside the lesions is currently unknown. It is possible that they were OPCs that downregulated PDGF>R in the lesion environment, especially given that most NG2 cells expressed Sox10. If this is the case, then downregulation of the PDGF>R may alter their responsiveness to molecular signals present in the lesions. For instance, OPCs respond differently to the combination of PDGF and basic fibroblast growth factor (bFGF) compared with either factor alone (55) . This is significant as bFGF levels are elevated after SCI (56, 57) . Furthermore, intracellular mechanisms have been described that link NG2, PDGF>R, and glutamate receptors in OPCs (2, 58) . Removal of PDGF>R from this complex will likely alter the OPC response to glutamate, which is also increased after SCI (59) . Interestingly, a recent study using a cortical stab model also noted a dissociation between PDGF>R and NG2 expression in the lesions (8) . Clearly, further studies are needed to determine the origin and function of single-labeled NG2 cells inside CNS lesions.
Schwann Cells as a Potential Source of NG2 in the Lesion
Schwann cells represent a plausible source of NG2 in the contusion lesions. Several studies have shown that Schwann cells migrate into the injured spinal cord and distribute throughout the lesion and spared tissue (28, 60Y64) . Migrating Schwann cells express p75 and laminin and typically display a bipolar morphology (60, 65, 66) , which was also true of most NG2 and p75 cells in the current study. On encountering bare axons, some Schwann cells downregulate p75, differentiate into a myelinating phenotype, and express myelin proteins such as P0. In our study, mature Schwann cells were not a likely source of NG2 because P0 profiles did not colocalize with NG2. Some Schwann cells, however, remain in the nonmyelinating stage after SCI and continue to express p75 (60) . In the current study, p75 expression in lesions increased over time and remained present chronically. Furthermore, approximately 84% of p75 + cells in the lesions expressed Sox10, the combination of which suggests a Schwann cell lineage. This is consistent with work by others showing NG2 expression by nonmyelinating Schwann cells (49, 67) . If most p75 cells in the lesions are indeed nonmyelinating Schwann cells but only 45% express NG2, there must be signals in the lesion milieu encountered by only a subset of cells that induce NG2 expression. Contact with axons may be involved, because studies have shown NG2 upregulation by direct axonYSchwann cell contact (20, 67) . Notably, p75 processes in contact with axons in the contusion lesions were observed in the current study as early as 7 dpi.
Another intriguing possibility is that NG2/p75 cells originated from a common CNS precursor rather than from the periphery. Evidence from the Blakemore group and others suggests a common CNS precursor exists for OPCs and Schwann cells (68Y71). Furthermore, cells doublelabeled for NG2 and p75 have been observed in multiple sclerosis (MS) plaques (72) . Indeed, samples from an active MS plaque revealed large numbers of spindle-shaped p75 cells in the subventricular zone (SVZ) and nearby plaque (73) . Similar to our data, the p75 cells in the plaque also expressed NG2, suggesting that p75 cells migrated from the SVZ into the plaque, at which point they upregulated NG2. Collectively, these studies suggest that the origin of cells responsive to CNS lesions is not straightforward or predictable and that a combination of sources is possible.
NG2 Expression by Other Cell Types in the Lesion
In the last several years, studies have shown that cells other than OPCs express NG2 in the injured or diseased CNS. For instance, NG2 expression by activated macrophages has been detected after SCI and excitotoxic lesions (12, 14, 16) and was again noted in the present study. Vascular pericytes also can express NG2 (17) . There is a robust angiogenic response after SCI, and NG2 + vessels were observed in the lesions (McTigue, personal observation), which contributed to overall NG2 levels. NG2 also has been detected on fibroblasts in peripheral nerves and meninges (18, 19, 25, 34, 67) , which are known to infiltrate the spinal cord after injury. However, in the current study, few cells were double-labeled for NG2 and fibronectin, suggesting that fibroblasts in the lesions contribute minimal NG2 after SCI.
Overall Summary
Spinal contusion results in a unique environment in which presumptions about cellular identity based on expression of single antigenic markers can be risky. For example, if sections had been labeled solely with NG2 or PDGF> receptor, one might assume that a large population of typical OPCs migrated into the lesions. However, it is clear from the present data that a seemingly endless number of immunohistochemical combinations are required to positively identify all cells within SCI lesions. Although the issue is still not completely resolved, the current results provide direction for possible future investigations. To date, most studies have suggested that NG2 is a potent inhibitor of axon growth. Because the SCI field has a clear need for mechanisms to increase axon growth, understanding the sources and roles of NG2 in the lesion site is important, especially given the large number of axons in close contact with NG2 cells and processes. If these NG2 cells are indeed OPCs, then an important question is why they do not differentiate into oligodendrocytes. If these cells are meningeal fibroblasts and/or Schwann cells, then a better understanding of the potential role of these cells in wound healing and repair is needed to determine if any axon growth inhibition is outweighed by beneficial effects within the lesion. Lastly, we need better insight on the influence of NG2 on axon growth in vivo. To date, studies demonstrating NG2-induced growth inhibition have mostly been performed in vitro. It needs to be determined if these results are truly replicated in the complex tissue environment of the traumatized CNS.
